Primary AML blasts (FLT3-ITD) when co-cultured on BMSC show increased apoptotic/annexin V positive cells when treated with daunorubicin in combination with ibrutinib (Fig. 3C). The gene discussed is FLT3; the disease is acute myeloid leukemia.